Difference between revisions of "ICRP Glossary"

From ICRPaedia
Jump to navigation Jump to search
(22 intermediate revisions by the same user not shown)
Line 15: Line 15:
 
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
 
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
  
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due course.
+
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being added progressively.
  
 
----
 
----
Line 33: Line 33:
 
*[[Acceptance test]]
 
*[[Acceptance test]]
  
*[[Access Control]]
+
*[[Access control]]
  
 
*[[Accountability]]
 
*[[Accountability]]
Line 43: Line 43:
 
*[[Activity median thermodynamic diameter]]
 
*[[Activity median thermodynamic diameter]]
  
*[[Acute Exposure]]
+
*[[Acute exposure]]
 +
 
 +
*Acute radiation sickness (see *[[Acute radiation syndrome]])
  
 
*[[Acute radiation syndrome]]
 
*[[Acute radiation syndrome]]
Line 53: Line 55:
 
*[[Adventitious]]
 
*[[Adventitious]]
  
*[[Adventitious Source]]
+
*[[Adventitious source]]
  
 
*[[Aerodynamic diameter ]]
 
*[[Aerodynamic diameter ]]
Line 70: Line 72:
  
 
*[[Alpha decay]]
 
*[[Alpha decay]]
 
*[[α/β ratio]]
 
  
 
*[[Alveolar-interstitial region]]
 
*[[Alveolar-interstitial region]]
Line 82: Line 82:
  
 
*[[Area monitoring]]
 
*[[Area monitoring]]
 +
 +
*ARS (see [[Acute radiation syndrome]])
  
 
*[[Attributable risk]]
 
*[[Attributable risk]]
Line 87: Line 89:
 
*[[Auger transition]]
 
*[[Auger transition]]
  
*[[Authorised Discharge]]
+
*[[Authorised discharge]]
  
 
*[[Authorization]]
 
*[[Authorization]]
Line 103: Line 105:
 
*[[Background dose (rate)]]
 
*[[Background dose (rate)]]
  
*[[Backscatter Factor ]]
+
*[[Backscatter factor]]
  
 
*[[Basal cell]]
 
*[[Basal cell]]
  
 
*[[Baseline disease rates]]
 
*[[Baseline disease rates]]
 +
 +
*BAT (see [[Best available techniques]])
  
 
*[[Beneficence]]
 
*[[Beneficence]]
Line 113: Line 117:
 
*[[Benthic]]
 
*[[Benthic]]
  
*[[Best Available Techniques]]
+
*[[Best available techniques]]
  
 
*[[Beta-minus decay]]
 
*[[Beta-minus decay]]
Line 198: Line 202:
  
 
=== <big><span id="D">D</span></big> ===
 
=== <big><span id="D">D</span></big> ===
 +
 +
*DD (see [[Doubling dose)]])
 +
 +
*DDREF (see [[Dose and dose-rate effectiveness factor)]])
  
 
*[[Decay constant]]
 
*[[Decay constant]]
Line 211: Line 219:
 
*[[Deterministic effect]]
 
*[[Deterministic effect]]
  
*[[Detriment]]
+
*Detriment (see [[Radiation detriment]])
  
 
*[[Detriment-adjusted risk]]
 
*[[Detriment-adjusted risk]]
Line 229: Line 237:
 
*[[Disposal]]
 
*[[Disposal]]
  
*[[Disposal Facility]]
+
*[[Disposal facility]]
  
 
*[[DNA damage signalling]]
 
*[[DNA damage signalling]]
  
*[[Dose and dose-rate effectiveness factor (DDREF)]]
+
*[[Dose and dose-rate effectiveness factor)]]
  
 
*[[Dose constraint]]
 
*[[Dose constraint]]
Line 243: Line 251:
 
*[[Dose limit]]
 
*[[Dose limit]]
  
*[[Dose Modifying Factor]]
+
*[[Dose modifying factor]]
  
 
*[[Dose per unit intake coefficient]]
 
*[[Dose per unit intake coefficient]]
Line 282: Line 290:
  
 
*[[Elemental dose]]
 
*[[Elemental dose]]
 +
 +
*ELR (see *[[Excess lifetime risk]])
  
 
*[[Emergency]]
 
*[[Emergency]]
Line 329: Line 339:
 
*[[Exposure, external or internal]]
 
*[[Exposure, external or internal]]
  
*[[Exposure Pathway]]
+
*[[Exposure pathway]]
  
 
*[[Exposure situation]]
 
*[[Exposure situation]]
Line 410: Line 420:
  
 
*[[Incidence]]
 
*[[Incidence]]
 +
 +
*Incidence rate (see [[Incidence]])
  
 
*[[Incident]]
 
*[[Incident]]
Line 423: Line 435:
 
*[[Induced genomic instability]]
 
*[[Induced genomic instability]]
  
*[[Informed Consent]]
+
*[[Informed consent]]
  
 
*[[Inhalability]]
 
*[[Inhalability]]
Line 484: Line 496:
  
 
*[[Linear-quadratic dose response]]
 
*[[Linear-quadratic dose response]]
 +
 +
*LLE (see [[Loss of Life Expectancy]])
  
 
*[[Loss of Life Expectancy]]
 
*[[Loss of Life Expectancy]]
Line 494: Line 508:
  
 
*[[Low level waste]]
 
*[[Low level waste]]
 +
 +
*LSS (see [[Life span study]])
  
 
*[[Lymphatic system]]
 
*[[Lymphatic system]]
Line 532: Line 548:
  
 
*[[Neurovascular syndrome]]
 
*[[Neurovascular syndrome]]
 +
 +
*NHEJ (see [[Non-homologous end joining]])
  
 
*[[Nominal risk coefficient]]
 
*[[Nominal risk coefficient]]
Line 578: Line 596:
  
 
*[[Platelet-derived growth factor]]
 
*[[Platelet-derived growth factor]]
 +
 +
*PLDR (see [[Potentially lethal damage repair]])
  
 
*[[Pooled analysis]]
 
*[[Pooled analysis]]
Line 649: Line 669:
 
*[[Radiographer]]
 
*[[Radiographer]]
  
*[[Radiological Controlled Area]]
+
*[[Radiological controlled area]]
  
 
*[[Radiological protection principles]]
 
*[[Radiological protection principles]]
Line 660: Line 680:
  
 
*[[Radiosensitivity, cellular]]
 
*[[Radiosensitivity, cellular]]
 +
 +
*RAP (see [[Reference Animal and Plant]])
 +
 +
*RBE (see [[Relative biological effectiveness]])
  
 
*[[Reactive oxygen species]]
 
*[[Reactive oxygen species]]
Line 678: Line 702:
  
 
*[[Reference level]]
 
*[[Reference level]]
 +
 +
*REID (see [[Risk of exposure-induced death]])
  
 
*[[Rehabilitation of living conditions]]
 
*[[Rehabilitation of living conditions]]
Line 724: Line 750:
  
 
*[[Risk of exposure-induced death]]
 
*[[Risk of exposure-induced death]]
 +
 +
*ROS (see [[Reactive oxygen species]])
  
 
*[[Routine monitoring]]
 
*[[Routine monitoring]]
 +
 +
*RR (see [[Relative risk]])
  
 
=== <big><span id="S">S</span></big> ===
 
=== <big><span id="S">S</span></big> ===
Line 740: Line 770:
  
 
*[[Severe deterministic injury]]
 
*[[Severe deterministic injury]]
 +
 +
*SLDR (see [[Sublethal damage repair]])
  
 
*[[Slow repair]]
 
*[[Slow repair]]
Line 777: Line 809:
 
*[[Substantial radiation dose level]]
 
*[[Substantial radiation dose level]]
  
*[[Supervised Area]]
+
*[[Supervised area]]
  
 
*[[Systemic model]]
 
*[[Systemic model]]
Line 823: Line 855:
  
 
*[[Transparency]]
 
*[[Transparency]]
 +
 +
*Transport of risk (see [[Transfer of risk]])
  
 
*[[Tumour suppressor gene]]
 
*[[Tumour suppressor gene]]
Line 849: Line 883:
  
 
*[[Wisdom]]
 
*[[Wisdom]]
 +
 +
*w<sub>T</sub> (see [[Tissue weighting factor]])
 +
 +
*w<sub>R</sub> (see [[Radiation weighting factor]])
  
 
=== <big><span id="X">X</span></big> ===
 
=== <big><span id="X">X</span></big> ===
Line 864: Line 902:
  
 
*[[α/β value]]
 
*[[α/β value]]
 +
 +
*α/β ratio (see [[α/β value]])
  
 
*[[γH2AX foci]]
 
*[[γH2AX foci]]
  
 
<div>
 
<div>

Revision as of 22:10, 24 February 2021

Glossary Header-left2.png





The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context.

Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary.

Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.

The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being added progressively.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ...

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

...